Bleomycin Pulmonary Toxicity in Adult Saudi Patients with Hodgkin's Lymphoma

被引：0
|
作者：
Al-Mansour, Mubarak M. [1 ]
Al-Jizani, Wafa A. [1 ]
Al-Fayea, Turki [1 ]
Ruaa, Shafi [1 ]
Kazkaz, Ghieth A. [2 ]
Bayer, Ali M. [2 ]
AL-Foheidi, Meteb [1 ]
Ibrahim, Ezzeldin M. [2 ]
机构：
[1] King Abdulaziz Med Ciity, Princess Norah Oncol Ctr, Jeddah, Saudi Arabia
[2] Int Med Ctr, Oncol Ctr Excellence, Jeddah, Saudi Arabia
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Bleomycin-Induced Lung Toxicity in Hodgkin's Lymphoma: Risk Factors in the Positron Emission Tomography Era
    Jennane, Selim
    Ababou, Mounir
    El Haddad, Mariyam
    Sahel, Omar Ait
    Mahtat, El Mehdi
    El Maaroufi, Hicham
    Doudouh, Abderrahim
    Doghmi, Kamal
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [42] G-CSF administration increases pulmonary toxicity for Hodgkin's disease patients treated with bleomycin-containing chemotherapy.
    Martin, WG
    Habermann, TM
    Colgan, JP
    Ristow, KM
    Ansell, SM
    BLOOD, 2004, 104 (11) : 371A - 371A
  • [43] Invited commentary on "The impact of bleomycin deficit on survival in Hodgkin's lymphoma patients: A retrospective study"
    Patra, Pritish Chandra
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2024, 40
  • [44] Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential
    Toltz, Allison
    Shin, Naomi
    Mitrou, Ellis
    Laude, Cecile
    Freeman, Carolyn R.
    Seuntjens, Jan
    Parker, William
    Roberge, David
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2015, 16 (05): : 167 - 178
  • [45] Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin's lymphoma
    Pepper, Niklas Benedikt
    Oertel, Michael
    Kittel, Christopher
    Kroeger, Kai Jannes
    Elsayad, Khaled
    Haverkamp, Uwe
    Eich, Hans Theodor
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (01) : 56 - 62
  • [46] Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
    Niklas Benedikt Pepper
    Michael Oertel
    Christopher Kittel
    Kai Jannes Kröger
    Khaled Elsayad
    Uwe Haverkamp
    Hans Theodor Eich
    Strahlentherapie und Onkologie, 2021, 197 : 56 - 62
  • [47] Pulmonary langerhans histiocytosis and Hodgkin's lymphoma
    Paris, A.
    Dib, M.
    Rousselet, M-C.
    Urban, T.
    Tazi, A.
    Gagnadoux, F.
    REVUE DES MALADIES RESPIRATOIRES, 2011, 28 (07) : 928 - 932
  • [48] Primary Pulmonary Paraganglioma with Hodgkin's Lymphoma
    Kavakli, K.
    Ozturk, M.
    Ongoru, O.
    Gurkok, S.
    Genc, O.
    THORACIC AND CARDIOVASCULAR SURGEON, 2009, 57 (06): : 375 - 377
  • [49] PULMONARY TOXICITY IN PATIENTS WITH NON-HODGKINS-LYMPHOMA TREATED WITH BLEOMYCIN-CONTAINING COMBINATION CHEMOTHERAPY
    NGAN, HYS
    LIANG, RHS
    LAM, WK
    CHAN, TK
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 32 (05) : 407 - 409
  • [50] NORMAL TISSUE COMPLICATION PROBABILITY MODEL FOR LUNG TOXICITY AFTER RADIOTHERAPY IN PEDIATRIC PATIENTS WITH HODGKIN LYMPHOMA RECEIVING BLEOMYCIN
    Konski, Andre
    Hallock, Abhirami
    Snyder, Michael
    McSpadden, Erin
    Weyh, Ashleigh
    Savasan, Sureyya
    Henry, Meret
    Cushing, Barbara
    Maier, Jordan
    Ravindranath, Yaddanapudi
    Bergman, David
    Taub, Jeffrey W.
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 981 - 981
12345